David Ridley is the Dr. and Mrs. Frank A. Riddick Professor of the Practice of Business Administration. He is also the Faculty Director of Duke's Health Sector Management program. In his research, David examines innovation and pricing, especially in health care. He was the lead author of the paper proposing the priority review voucher program to encourage development of drugs for neglected diseases. The voucher program became law in the U.S. in 2007 and the market price of vouchers has been more than $100 million. David has published in economics journals (Journal of Public Economics ), medical journals (Journal of the American Medical Association ), and scientific journals (Nature Reviews Drug Discovery ). David teaches in the daytime MBA and executive MBA programs.
Ridley DB, Lee CY. Does medicare reimbursement drive up drug launch prices? Review of Economics and Statistics. 2020 Dec 1;102(5):980–93.
Kyle MK, Ridley DB, Zhang S. Strategic interaction among governments in the provision of a global public good. Journal of Public Economics. 2017 Dec 1;156:185–99.
Ridley DB, Moe JL, Hamon N. A Voucher System To Speed Review Could Promote A New Generation Of Insecticides To Fight Vector-Borne Diseases. Health Affairs (Project Hope). 2017 Aug;36(8):1461–8.